Tcng

TCNG The Cancer Network Galaxy0.14

Database of Cancer Gene Networks from Public Gene Expression Data


Warning: Undefined array key "network" in /hshare1/ZETTAI_path_WA_slash_usr_slash_proj_KARA/usr/proj/tcng/htdocs/tcng.php on line 565

Edge

RAC2 → PIM1

Parent NodeRAC2
Genes in Parent NodeRAC2
Child NodePIM1
Genes in Child NodePIM1

Networks Including this Edge

GSE15396_egf1520 - GSE15396 - SiGN-BN HC+BootstrapPeripheral blood mononuclear, DU145, and HCT116 cells treated with a CDK inhibitor
GSE20257_egf1520 - GSE20257 - SiGN-BN HC+BootstrapSmoking-induced Disarray of the Apical Junctional Complex Gene Expression Architecture in the Human Airway Epithelium
GSE21501_egf1520 - GSE21501 - SiGN-BN HC+BootstrapA six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma
GSE23988_egf1520 - GSE23988 - SiGN-BN HC+BootstrapExpression data from breast cancer FNA biopsies from patients (US samples)
GSE24124_egf1520 - GSE24124 - SiGN-BN HC+BootstrapMajor gene partners of a favorable biomarker in ER(+) breast cancer
GSE24185_egf1520 - GSE24185 - SiGN-BN HC+BootstrapGene transcription signature of obesity in breast cancer
GSE25065_egf1520 - GSE25065 - SiGN-BN HC+BootstrapValidation cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer
GSE2841_egf1520 - GSE2841 - SiGN-BN HC+BootstrapExpression Profiling of pheochromocytomas of various genetic origins
GSE3143_egf1520 - GSE3143 - SiGN-BN HC+BootstrapBreast Cancer Dataset
GSE32269_egf1520 - GSE32269 - SiGN-BN HC+BootstrapExpression data for primary localized prostate cancer versus castration-resistant bone metastatic prostate cancer
GSE4115_egf1520 - GSE4115 - SiGN-BN HC+BootstrapAirway Epithelial Gene Expression Diagnostic for the Evaluation of Smokers with Suspect Lung Cancer
GSE4573_egf1520 - GSE4573 - SiGN-BN HC+BootstrapGene expression signatures for predicting prognosis of squamous cell lung carcinomas
GSE5851_egf1520 - GSE5851 - SiGN-BN HC+BootstrapPhase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC